Submitted by Andrea Walker on Tue, 11/12/2018 - 14:24
The Secretary of State for Health and Social Care, Matt Hancock, has announced up to £100 million of public capital for an innovative children’s hospital for the east of England. This will be a new facility that is purpose-built to meet the needs of the region’s youngest patients, integrating mental and physical health and combining the highest quality services with world class science and research.
Built on land adjacent to Addenbrooke’s and the Rosie Hospitals, the children’s hospital will bring together some of the world’s top scientists to explore new ways of diagnosing and treating some of the most challenging diseases of childhood. Mapping the whole human genome and understanding the genetic basis of disease and recovery is central to the hospital’s vision. It aims to make an important contribution globally to the development of children’s healthcare while providing world class care for families in the east of England.
The project is a partnership involving Cambridge University Hospitals (CUH) NHS Foundation Trust, Cambridgeshire and Peterborough NHS Foundation Trust and the University of Cambridge. The development is a major part of the strategy to invest in world class facilities led by the Sustainability and Transformation Partnership for Cambridgeshire and Peterborough.
The Vice-Chancellor of the University of Cambridge, Professor Stephen Toope, said: “The announcement from the Secretary of State is extremely positive. It is not only an investment in the research and clinical expertise in Cambridge but, importantly, it is an investment in the future of our children and young people. By helping us to improve how we treat those young people unfortunate enough to be affected by serious childhood diseases, the new hospital has the potential to transform the provision of healthcare for families in the East of England.”
Read the full article on the University of Cambridge news pages.
The text in this work is licensed under a Creative Commons Attribution 4.0 International License.
